Browse our comprehensive archive of press releases by date.
Select a specific day to access all press releases published on Technology Times New Jersey.
Press releases published on September 3, 2025
TG Therapeutics Announces Completion of Existing Share Repurchase Program and Authorization of New $100 Million Program
GlobeNewswire
·
September 3, 2025
NEW YORK, Sept. 03, 2025 (GLOBE NEWSWIRE) -- TG Therapeutics, Inc. (NASDAQ: TGTX) today announced that it has completed its previously authorized $100 million share repurchase program, which was initially announced in August 2024. Under that program, the …
Vaxcyte Advances VAX-31 Infant Phase 2 Dose-Finding Study with First Participants Receiving VAX-31 Optimized Dose
GlobeNewswire
·
September 3, 2025
VAX-31 Optimized Dose, with Majority of Serotypes Dosed at 4.4mcg and Balance at 3.3mcg, is Designed to Elicit Even Stronger Immune Responses in Infant Population to Protect Against Invasive Pneumococcal Disease (IPD) Company Intends to Release Topline …
MicrobiotiX Finalizes KRW 20 Billion Series B, Securing Korea's First Bacteriophage Clinical Trial
GlobeNewswire
·
September 3, 2025
SEOUL, South Korea, Sept. 03, 2025 (GLOBE NEWSWIRE) -- MicrobiotiX, a biotech developing novel bacteriophage-based therapeutics, announced on the 29th that it has completed an extended Series B investment round totaling 20 billion KRW. MicrobiotiX’s …
Free Mark Cuban Foundation AI Bootcamp Coming to Houston This Fall
GlobeNewswire
·
September 3, 2025
HOUSTON, Sept. 03, 2025 (GLOBE NEWSWIRE) -- The Mark Cuban Foundation, in partnership with Air Liquide will host a no-cost Artificial Intelligence Bootcamp for high school students in Houston this fall. The program is open to students in grades 9–12 and …
Draganfly Demonstrates the Commander 3XL and Flex FPV Capabilities at T-REX 24-2 Military Technology Exercise
GlobeNewswire
·
September 3, 2025
Demonstrations validate Commander 3XL and Flex FPV capabilities in multi-domain defense operations at T-REX 24-2. Camp Atterbury, Indiana, Sept. 03, 2025 (GLOBE NEWSWIRE) -- Draganfly Inc. (NASDAQ: DPRO) (CSE: DPRO) (FSE: 3U8) (“Draganfly” or the “Company …
تتعاون شركة Synopsis مع Telnyx لطرح تقنيات اتصالات قابلة للتوسع وVoice AI في منطقة الشرق الأوسط وشمال إفريقيا
GlobeNewswire
·
September 3, 2025
AUSTIN, Sept. 03, 2025 (GLOBE NEWSWIRE) -- أعلنت Telnyx، المنصة المتكاملة للذكاء الاصطناعي الحواري التي تدعم الاتصالات العالمية، عن عقد شراكة جديدة مع Synopsis، الموزع الرائد للتكنولوجيا في أسواق الشرق الأوسط وإفريقيا. سيفتح هذا التعاون آفاقًا جديدةً …
Breckenridge Distillery Expands California Distribution with Winebow
GlobeNewswire
·
September 3, 2025
BRECKENRIDGE, Colo., Sept. 03, 2025 (GLOBE NEWSWIRE) -- Breckenridge Distillery, an award-winning craft distillery and spirits brand owned by Tilray Brands, Inc. (NASDAQ: TLRY; TSX: TLRY), has announced a strategic change in its California distribution …
BioCryst Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
GlobeNewswire
·
September 3, 2025
RESEARCH TRIANGLE PARK, N.C., Sept. 03, 2025 (GLOBE NEWSWIRE) -- BioCryst Pharmaceuticals, Inc. (Nasdaq: BCRX) today announced that the compensation committee of BioCryst’s board of directors granted nine newly-hired employees stock options to purchase an …
Climb Channel Solutions Announces North American Distribution Partnership with Forcepoint to Deliver Data Security Everywhere
GlobeNewswire
·
September 3, 2025
EATONTOWN, N.J., Sept. 03, 2025 (GLOBE NEWSWIRE) -- Climb Channel Solutions, an international specialty technology distributor and wholly owned subsidiary of Climb Global Solutions, Inc. (NASDAQ: CLMB) announces North American Distribution Partnership with …
TScan Therapeutics to Participate in Upcoming Investor Conferences
GlobeNewswire
·
September 3, 2025
WALTHAM, Mass., Sept. 03, 2025 (GLOBE NEWSWIRE) -- TScan Therapeutics, Inc. (Nasdaq: TCRX), a clinical-stage biotechnology company focused on the development of T cell receptor (TCR)-engineered T cell (TCR-T) therapies for the treatment of patients with …
Aura Biosciences to Participate in the H.C. Wainwright 27th Annual Global Investment Conference
GlobeNewswire
·
September 3, 2025
BOSTON, Sept. 03, 2025 (GLOBE NEWSWIRE) -- Aura Biosciences, Inc. (NASDAQ: AURA), a clinical-stage biotechnology company developing precision therapies for solid tumors designed to preserve organ function, today announced that Elisabet de los Pinos, PhD, …
Istios Health Partners with Infectious Diseases Associates of Central Virginia
GlobeNewswire
·
September 3, 2025
PHOENIX, Sept. 03, 2025 (GLOBE NEWSWIRE) -- Istios Health, a healthcare technology company transforming infectious disease (ID) and related care through integrated clinical services, real-world data, and research-enabled networks, today announced a …
Kymera Therapeutics Appoints Brian Adams as Chief Legal Officer and Corporate Secretary
GlobeNewswire
·
September 3, 2025
WATERTOWN, Mass., Sept. 03, 2025 (GLOBE NEWSWIRE) -- Kymera Therapeutics, Inc. (NASDAQ: KYMR), a clinical-stage biopharmaceutical company advancing a new class of oral small molecule degrader medicines for immunological diseases, today announced the …
Centessa Pharmaceuticals to Participate in the Morgan Stanley 23rd Annual Global Healthcare Conference
GlobeNewswire
·
September 3, 2025
BOSTON and LONDON, Sept. 03, 2025 (GLOBE NEWSWIRE) -- Centessa Pharmaceuticals plc (Nasdaq: CNTA), a clinical-stage pharmaceutical company that aims to discover and develop transformational medicines for patients, today announced that members of its …
C4 Therapeutics to Present Data from the Phase 1 Trial of Cemsidomide in Multiple Myeloma at the International Myeloma Society (IMS) Annual Meeting
GlobeNewswire
·
September 3, 2025
WATERTOWN, Mass., Sept. 03, 2025 (GLOBE NEWSWIRE) -- C4 Therapeutics, Inc. (C4T) (Nasdaq: CCCC), a clinical-stage biopharmaceutical company dedicated to advancing targeted protein degradation science, today announced that data from its Phase 1 dose …
MediciNova to Present at the H.C. Wainwright 27th Annual Global Investment Conference
GlobeNewswire
·
September 3, 2025
LA JOLLA, Calif., Sept. 03, 2025 (GLOBE NEWSWIRE) -- MediciNova, Inc., a biopharmaceutical company traded on the NASDAQ Global Market (NASDAQ:MNOV) and the Standard Market of the Tokyo Stock Exchange (Code Number: 4875) (the “Company”), announces that …
ProMIS Neurosciences Receives DSMB Approval to Advance to Final Dose Escalation Cohort in Phase 1b Alzheimer’s Trial of PMN310
GlobeNewswire
·
September 3, 2025
Cohort 2 fully enrolled; enrollment and dosing now underway for Cohort 3 (final dose level); No cases of amyloid-related imaging abnormalities (ARIA) observed to date; The trial, expected to enroll 128 patients, remains on track to report 6-month interim …
XORTX Initiates IND Preparation for XORLO™ in Gout Program
GlobeNewswire
·
September 3, 2025
CALGARY, Alberta, Sept. 03, 2025 (GLOBE NEWSWIRE) -- XORTX Therapeutics Inc. (“XORTX” or the “Company”) (NASDAQ: XRTX | TSXV: XRTX | Frankfurt: ANU), a late stage clinical pharmaceutical company focused on developing innovative therapies to treat gout and …
Mintland Launches to Democratize Real Estate Investing Through Blockchain
GlobeNewswire
·
September 3, 2025
Dubai, UAE, Sept. 03, 2025 (GLOBE NEWSWIRE) -- Mintland, an innovative blockchain-powered platform, has officially launched with the mission to make real estate investing accessible to everyone, regardless of income level or location. By tokenizing premium …
SINTX Technologies Publishes Landmark Study Demonstrating Broad-Spectrum Antiviral Activity of Silicon Nitride
GlobeNewswire
·
September 3, 2025
Breakthrough findings open doors to multi-billion-dollar infection-control markets SALT LAKE CITY, Utah, Sept. 03, 2025 (GLOBE NEWSWIRE) -- SINTX Technologies, Inc. (NASDAQ: SINT) (“SINTX” or the “Company”), an advanced ceramics innovator specializing in …